Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
The call can be accessed via teleconference at: Q2 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/rcm5foqd
A replay of the conference call and webcast will be available for one year beginning on
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: |
|
|
David Trenk, Manager-Investor Relations |
(781) 356-9763 |
(203) 733-4987 |
|
|
Media Contact: |
|
|
|
(781) 356-9776 |
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2025-results-november-7-2024-302267183.html
SOURCE